The maker’s program

FreeStyle Libre systems Copay Card

Savings card from Abbott

Commercial insurance or none. Its page doesn’t list a dollar amount.

For people with private insurance or no insurance; not for Medicare, Medicaid or other government coverage. Abbott says the amount you pay may vary.

See it on freestyle.abbott 

In the maker’s words

“If you are privately insured or uninsured and asked to pay over $75 for two sensors, our Copay Card can help you save!”

From the maker’s page on freestyle.abbott, checked November 17, 2026.

From Abbott’s own website, in its own words. DrugAlt reads each page again every week.

More ways to pay less

What it is

A small sensor worn on the skin that reads glucose (sugar) around the clock and sends the readings to a phone app or reader.

Used for: Tracking glucose (sugar) levels in diabetes; Spotting episodes of high and low glucose (sugar); Replacing fingerstick blood glucose tests for diabetes treatment decisions, unless otherwise directed.

In the FDA’s records’ words

Percutaneous interstitial fluid glucose monitoring system, electrochemical. An assembly of electrically-powered, portable devices intended to continuously monitor interstitial fluid glucose concentrations in a patient with diabetes mellitus, using an invasive electrochemical technique. It consists of an electrochemical, percutaneously-inserted electrode that physically connects to a cable or transmitter which communicates with a monitor or receiver (not included) that captures, stores, and converts the sensor signals to glucose concentrations for display. The system may be used in the home and clinical settings, and aids in the detection of episodes of hyperglycaemia and hypoglycaemia, facilitating acute/long-term therapy adjustments.

Integrated continuous glucose monitoring system, factory calibrated, not for use with automated insulin delivery systems. An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data to digitally connected devices and are intended to be used alone or in conjunction with these digitally connected devices where the user manually controls actions for therapy decisions. The system is not intended to be used with automated insulin dosing (AID) systems.

Only your prescriber can say whether a device is right for you.

In the FDA’s device database

6 versions sold now

Each opens its FDA record. The model number is on the box.

Show all 6

Source: the FDA’s device database (GUDID), November 2, 2026.

Similar devices

All 9 continuous glucose monitors